Bristol-myers' Gets Early Approval Of Combo Cancer Treatment

Bristol-Myers takes lead with approval of first combo of immune system-boosting cancer drugs

Topics:  bristol-myers   approval   combo   cancer   
BING NEWS:
  • Immunotherapy Combination Shows Promise for Early-Stage ERBB2-Positive Breast Cancer
    A recent Phase 1 clinical trial has provided promising results for a novel immunotherapy approach to treat early-stage ERBB2-positive breast cancer. Read on!
    01/2/2025 - 8:00 pm | View Link
  • Bristol Myers celebrates 10 years of Opdivo with FDA approval for subcutaneous version
    Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in the U.S., the agency has cleared an under-the-skin version of the cancer ...
    01/2/2025 - 12:15 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News